Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth L Wilder

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The Physiologist|November 20, 2012
Common Fund programs: what are they and are you eligible for funding?Elizabeth L Wilder
Science (New York, N.Y.)|July 19, 2014
Funding transdisciplinary research. NIH Roadmap/Common Fund at 10 yearsFrancis S Collins, Elizabeth L Wilder, Elias Zerhouni
Science Advances|November 10, 2021
Validation of antibodies: Lessons learned from the Common Fund Protein Capture Reagents ProgramAnanda L Roy, Elizabeth L Wilder, James M Anderson
Science (New York, N.Y.)|November 16, 2013
Biomedical research: strength from diversityElizabeth L Wilder, Lawrence A Tabak, Roderic I Pettigrew, et al.
Cancer Research|January 10, 2002
Wnt-1 but not epidermal growth factor induces beta-catenin/T-cell factor-dependent transcription in esophageal cancer cellsTakaaki Mizushima, Hiroshi Nakagawa, Yana G Kamberov, et al.
Science Advances|August 8, 2018
Accelerating a paradigm shift: The Common Fund Single Cell Analysis ProgramAnanda L Roy, Richard Conroy, Jessica Smith, et al.
Developmental Cell|April 24, 2002
DWnt4 regulates cell movement and focal adhesion kinase during Drosophila ovarian morphogenesisE David Cohen, Marie-Christine Mariol, Rachel M H Wallace, et al.
Plos Computational Biology|December 3, 2005
NIH Roadmap interdisciplinary research initiativesMichael F Huerta, Gregory K Farber, Elizabeth L Wilder, et al.
Cell|October 31, 2020
A Blueprint for Characterizing SenescenceAnanda L Roy, Felipe Sierra, Kevin Howcroft, et al.
Science Advances|September 11, 2019
The NIH Common Fund/Roadmap Epigenomics Program: Successes of a comprehensive consortiumJohn S Satterlee, Lisa H Chadwick, Frederick L Tyson, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Physiologist|November 20, 2012
Common Fund programs: what are they and are you eligible for funding?Elizabeth L Wilder
Science (New York, N.Y.)|July 19, 2014
Funding transdisciplinary research. NIH Roadmap/Common Fund at 10 yearsFrancis S Collins, Elizabeth L Wilder, Elias Zerhouni
Science Advances|November 10, 2021
Validation of antibodies: Lessons learned from the Common Fund Protein Capture Reagents ProgramAnanda L Roy, Elizabeth L Wilder, James M Anderson
Science (New York, N.Y.)|November 16, 2013
Biomedical research: strength from diversityElizabeth L Wilder, Lawrence A Tabak, Roderic I Pettigrew, et al.
Cancer Research|January 10, 2002
Wnt-1 but not epidermal growth factor induces beta-catenin/T-cell factor-dependent transcription in esophageal cancer cellsTakaaki Mizushima, Hiroshi Nakagawa, Yana G Kamberov, et al.
Science Advances|August 8, 2018
Accelerating a paradigm shift: The Common Fund Single Cell Analysis ProgramAnanda L Roy, Richard Conroy, Jessica Smith, et al.
Developmental Cell|April 24, 2002
DWnt4 regulates cell movement and focal adhesion kinase during Drosophila ovarian morphogenesisE David Cohen, Marie-Christine Mariol, Rachel M H Wallace, et al.
Plos Computational Biology|December 3, 2005
NIH Roadmap interdisciplinary research initiativesMichael F Huerta, Gregory K Farber, Elizabeth L Wilder, et al.
Cell|October 31, 2020
A Blueprint for Characterizing SenescenceAnanda L Roy, Felipe Sierra, Kevin Howcroft, et al.
Science Advances|September 11, 2019
The NIH Common Fund/Roadmap Epigenomics Program: Successes of a comprehensive consortiumJohn S Satterlee, Lisa H Chadwick, Frederick L Tyson, et al.
Pageof 2